Text and Data Mining valid from 2018-07-18
Received: 27 April 2018
Accepted: 11 June 2018
First Online: 18 July 2018
: S.P.J. receives some research funding from AstraZeneca and is a named inventor on patents describing the use of PARP inhibitors in cancer therapy. V.S.’s laboratory receives research funding support from AstraZeneca. M.O. and Z.L. are employees and shareholders of AstraZeneca.